SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-18-012640
Filing Date
2018-11-07
Accepted
2018-11-07 17:07:54
Documents
2
Period of Report
2018-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1694
2 poawood.txt EX-24 3683
  Complete submission text file 0001179110-18-012640.txt   6876
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address
Woodman Richard Charles (Reporting) CIK: 0001758427 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36020 | Film No.: 181167276